Upgrade to SI Premium - Free Trial

Vir Biotechnology (VIR) Stock Soars on Early Omicron Testing Data

December 2, 2021 6:03 AM
Shares of Vir Biotechnology (NASDAQ: VIR) are up nearly 9% after the company said that preliminary data shows that its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments FDA Hot FDA News Momentum Movers Trader Talk

Next Articles